nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—ABCG2—primary biliary cirrhosis	0.346	0.696	CbGaD
Imatinib—ALB—primary biliary cirrhosis	0.151	0.304	CbGaD
Imatinib—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.0265	0.311	CbGbCtD
Imatinib—CYP2C9—Colchicine—primary biliary cirrhosis	0.0231	0.27	CbGbCtD
Imatinib—ABCB1—Colchicine—primary biliary cirrhosis	0.0224	0.262	CbGbCtD
Imatinib—CYP3A4—Colchicine—primary biliary cirrhosis	0.0134	0.157	CbGbCtD
Imatinib—ORM1—bile—primary biliary cirrhosis	0.00767	0.132	CbGeAlD
Imatinib—CA9—gall bladder—primary biliary cirrhosis	0.00363	0.0623	CbGeAlD
Imatinib—DDR1—smooth muscle tissue—primary biliary cirrhosis	0.0032	0.055	CbGeAlD
Imatinib—PDGFRA—gall bladder—primary biliary cirrhosis	0.00291	0.0499	CbGeAlD
Imatinib—KIT—gall bladder—primary biliary cirrhosis	0.00232	0.0399	CbGeAlD
Imatinib—PDGFRB—gall bladder—primary biliary cirrhosis	0.00227	0.039	CbGeAlD
Imatinib—ORM1—gall bladder—primary biliary cirrhosis	0.00213	0.0365	CbGeAlD
Imatinib—DDR1—liver—primary biliary cirrhosis	0.00188	0.0324	CbGeAlD
Imatinib—ALB—gall bladder—primary biliary cirrhosis	0.00187	0.032	CbGeAlD
Imatinib—Ponatinib—ABCG2—primary biliary cirrhosis	0.00171	0.575	CrCbGaD
Imatinib—PDGFRA—smooth muscle tissue—primary biliary cirrhosis	0.00145	0.0249	CbGeAlD
Imatinib—CA2—gall bladder—primary biliary cirrhosis	0.00138	0.0236	CbGeAlD
Imatinib—CSF1R—smooth muscle tissue—primary biliary cirrhosis	0.00128	0.0219	CbGeAlD
Imatinib—Nilotinib—ABCG2—primary biliary cirrhosis	0.00126	0.425	CrCbGaD
Imatinib—ABL2—liver—primary biliary cirrhosis	0.00123	0.0211	CbGeAlD
Imatinib—KIT—epithelium—primary biliary cirrhosis	0.0012	0.0206	CbGeAlD
Imatinib—PDGFRB—epithelium—primary biliary cirrhosis	0.00117	0.0202	CbGeAlD
Imatinib—PIP4K2C—liver—primary biliary cirrhosis	0.00116	0.02	CbGeAlD
Imatinib—KIT—smooth muscle tissue—primary biliary cirrhosis	0.00116	0.0199	CbGeAlD
Imatinib—PDGFRB—smooth muscle tissue—primary biliary cirrhosis	0.00113	0.0194	CbGeAlD
Imatinib—CA3—liver—primary biliary cirrhosis	0.00111	0.0191	CbGeAlD
Imatinib—LCK—liver—primary biliary cirrhosis	0.00103	0.0177	CbGeAlD
Imatinib—CA14—liver—primary biliary cirrhosis	0.00101	0.0173	CbGeAlD
Imatinib—ABL1—smooth muscle tissue—primary biliary cirrhosis	0.00101	0.0173	CbGeAlD
Imatinib—CYP3A7—liver—primary biliary cirrhosis	0.000987	0.0169	CbGeAlD
Imatinib—NQO2—liver—primary biliary cirrhosis	0.000854	0.0147	CbGeAlD
Imatinib—PDGFRA—liver—primary biliary cirrhosis	0.000852	0.0146	CbGeAlD
Imatinib—CYP3A7-CYP3A51P—liver—primary biliary cirrhosis	0.000839	0.0144	CbGeAlD
Imatinib—CSF1R—liver—primary biliary cirrhosis	0.00075	0.0129	CbGeAlD
Imatinib—CA2—epithelium—primary biliary cirrhosis	0.000713	0.0122	CbGeAlD
Imatinib—CA2—smooth muscle tissue—primary biliary cirrhosis	0.000687	0.0118	CbGeAlD
Imatinib—SLC47A1—liver—primary biliary cirrhosis	0.000685	0.0118	CbGeAlD
Imatinib—KIT—liver—primary biliary cirrhosis	0.000681	0.0117	CbGeAlD
Imatinib—PDGFRB—liver—primary biliary cirrhosis	0.000665	0.0114	CbGeAlD
Imatinib—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.000665	0.00288	CcSEcCtD
Imatinib—Pancytopenia—Colchicine—primary biliary cirrhosis	0.000653	0.00283	CcSEcCtD
Imatinib—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.000653	0.00283	CcSEcCtD
Imatinib—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.000653	0.00283	CcSEcCtD
Imatinib—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000646	0.0028	CcSEcCtD
Imatinib—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000646	0.0028	CcSEcCtD
Imatinib—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000644	0.00279	CcSEcCtD
Imatinib—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000644	0.00279	CcSEcCtD
Imatinib—Cramp muscle—Chenodeoxycholic acid—primary biliary cirrhosis	0.000644	0.00279	CcSEcCtD
Imatinib—Cramp muscle—Ursodeoxycholic acid—primary biliary cirrhosis	0.000644	0.00279	CcSEcCtD
Imatinib—Neutropenia—Colchicine—primary biliary cirrhosis	0.000643	0.00279	CcSEcCtD
Imatinib—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000632	0.00274	CcSEcCtD
Imatinib—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000632	0.00274	CcSEcCtD
Imatinib—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00063	0.00274	CcSEcCtD
Imatinib—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00063	0.00274	CcSEcCtD
Imatinib—ORM1—liver—primary biliary cirrhosis	0.000624	0.0107	CbGeAlD
Imatinib—CA1—liver—primary biliary cirrhosis	0.000623	0.0107	CbGeAlD
Imatinib—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000618	0.00268	CcSEcCtD
Imatinib—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.000618	0.00268	CcSEcCtD
Imatinib—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.000618	0.00268	CcSEcCtD
Imatinib—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000618	0.00268	CcSEcCtD
Imatinib—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000606	0.00263	CcSEcCtD
Imatinib—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000606	0.00263	CcSEcCtD
Imatinib—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.000602	0.00261	CcSEcCtD
Imatinib—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.000602	0.00261	CcSEcCtD
Imatinib—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.000601	0.00261	CcSEcCtD
Imatinib—Stomatitis—Colchicine—primary biliary cirrhosis	0.000597	0.00259	CcSEcCtD
Imatinib—ABL1—liver—primary biliary cirrhosis	0.000593	0.0102	CbGeAlD
Imatinib—Haematuria—Colchicine—primary biliary cirrhosis	0.000584	0.00254	CcSEcCtD
Imatinib—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00249	CcSEcCtD
Imatinib—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00249	CcSEcCtD
Imatinib—Agranulocytosis—Colchicine—primary biliary cirrhosis	0.000572	0.00248	CcSEcCtD
Imatinib—SLC22A1—liver—primary biliary cirrhosis	0.000572	0.00981	CbGeAlD
Imatinib—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000571	0.00248	CcSEcCtD
Imatinib—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000571	0.00248	CcSEcCtD
Imatinib—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000564	0.00245	CcSEcCtD
Imatinib—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000564	0.00245	CcSEcCtD
Imatinib—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000562	0.00244	CcSEcCtD
Imatinib—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000562	0.00244	CcSEcCtD
Imatinib—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000559	0.00243	CcSEcCtD
Imatinib—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000559	0.00243	CcSEcCtD
Imatinib—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000554	0.0024	CcSEcCtD
Imatinib—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000554	0.0024	CcSEcCtD
Imatinib—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000551	0.00239	CcSEcCtD
Imatinib—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000551	0.00239	CcSEcCtD
Imatinib—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000551	0.00239	CcSEcCtD
Imatinib—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000551	0.00239	CcSEcCtD
Imatinib—PTGS1—epithelium—primary biliary cirrhosis	0.00055	0.00945	CbGeAlD
Imatinib—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.000549	0.00238	CcSEcCtD
Imatinib—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.000549	0.00238	CcSEcCtD
Imatinib—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.000547	0.00238	CcSEcCtD
Imatinib—ALB—liver—primary biliary cirrhosis	0.000547	0.0094	CbGeAlD
Imatinib—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.000543	0.00236	CcSEcCtD
Imatinib—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.000543	0.00236	CcSEcCtD
Imatinib—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000541	0.00235	CcSEcCtD
Imatinib—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000541	0.00235	CcSEcCtD
Imatinib—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00054	0.00234	CcSEcCtD
Imatinib—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00054	0.00234	CcSEcCtD
Imatinib—Jaundice—Ursodeoxycholic acid—primary biliary cirrhosis	0.000537	0.00233	CcSEcCtD
Imatinib—Jaundice—Chenodeoxycholic acid—primary biliary cirrhosis	0.000537	0.00233	CcSEcCtD
Imatinib—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000535	0.00232	CcSEcCtD
Imatinib—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000535	0.00232	CcSEcCtD
Imatinib—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000535	0.00232	CcSEcCtD
Imatinib—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000535	0.00232	CcSEcCtD
Imatinib—PTGS1—smooth muscle tissue—primary biliary cirrhosis	0.00053	0.0091	CbGeAlD
Imatinib—Sweating—Ursodeoxycholic acid—primary biliary cirrhosis	0.000528	0.00229	CcSEcCtD
Imatinib—Sweating—Chenodeoxycholic acid—primary biliary cirrhosis	0.000528	0.00229	CcSEcCtD
Imatinib—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000525	0.00228	CcSEcCtD
Imatinib—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000525	0.00228	CcSEcCtD
Imatinib—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.000521	0.00226	CcSEcCtD
Imatinib—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.000521	0.00226	CcSEcCtD
Imatinib—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000519	0.00225	CcSEcCtD
Imatinib—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000519	0.00225	CcSEcCtD
Imatinib—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000517	0.00224	CcSEcCtD
Imatinib—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000517	0.00224	CcSEcCtD
Imatinib—Eye disorder—Colchicine—primary biliary cirrhosis	0.000514	0.00223	CcSEcCtD
Imatinib—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000497	0.00216	CcSEcCtD
Imatinib—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000497	0.00216	CcSEcCtD
Imatinib—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000496	0.00215	CcSEcCtD
Imatinib—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000496	0.00215	CcSEcCtD
Imatinib—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000496	0.00215	CcSEcCtD
Imatinib—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000494	0.00215	CcSEcCtD
Imatinib—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000494	0.00215	CcSEcCtD
Imatinib—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000491	0.00213	CcSEcCtD
Imatinib—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000491	0.00213	CcSEcCtD
Imatinib—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000488	0.00212	CcSEcCtD
Imatinib—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000488	0.00212	CcSEcCtD
Imatinib—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000487	0.00211	CcSEcCtD
Imatinib—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000487	0.00211	CcSEcCtD
Imatinib—Alopecia—Colchicine—primary biliary cirrhosis	0.000486	0.00211	CcSEcCtD
Imatinib—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000486	0.00211	CcSEcCtD
Imatinib—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000486	0.00211	CcSEcCtD
Imatinib—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000485	0.0021	CcSEcCtD
Imatinib—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000485	0.0021	CcSEcCtD
Imatinib—Malnutrition—Colchicine—primary biliary cirrhosis	0.000479	0.00208	CcSEcCtD
Imatinib—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000462	0.00201	CcSEcCtD
Imatinib—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000462	0.00201	CcSEcCtD
Imatinib—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000461	0.002	CcSEcCtD
Imatinib—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000461	0.002	CcSEcCtD
Imatinib—Muscle spasms—Colchicine—primary biliary cirrhosis	0.000461	0.002	CcSEcCtD
Imatinib—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000459	0.00199	CcSEcCtD
Imatinib—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000459	0.00199	CcSEcCtD
Imatinib—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000449	0.00195	CcSEcCtD
Imatinib—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000449	0.00195	CcSEcCtD
Imatinib—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000447	0.00194	CcSEcCtD
Imatinib—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000447	0.00194	CcSEcCtD
Imatinib—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000446	0.00193	CcSEcCtD
Imatinib—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000446	0.00193	CcSEcCtD
Imatinib—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.000444	0.00193	CcSEcCtD
Imatinib—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.000444	0.00193	CcSEcCtD
Imatinib—Anaemia—Colchicine—primary biliary cirrhosis	0.000443	0.00192	CcSEcCtD
Imatinib—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000442	0.00192	CcSEcCtD
Imatinib—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000442	0.00192	CcSEcCtD
Imatinib—CYP2C19—liver—primary biliary cirrhosis	0.000441	0.00757	CbGeAlD
Imatinib—Angioedema—Colchicine—primary biliary cirrhosis	0.000438	0.0019	CcSEcCtD
Imatinib—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000437	0.0019	CcSEcCtD
Imatinib—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000437	0.0019	CcSEcCtD
Imatinib—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00043	0.00187	CcSEcCtD
Imatinib—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00043	0.00187	CcSEcCtD
Imatinib—Leukopenia—Colchicine—primary biliary cirrhosis	0.000429	0.00186	CcSEcCtD
Imatinib—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000424	0.00184	CcSEcCtD
Imatinib—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000424	0.00184	CcSEcCtD
Imatinib—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000416	0.00181	CcSEcCtD
Imatinib—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000416	0.00181	CcSEcCtD
Imatinib—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.000414	0.0018	CcSEcCtD
Imatinib—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.000414	0.0018	CcSEcCtD
Imatinib—Arthralgia—Colchicine—primary biliary cirrhosis	0.000408	0.00177	CcSEcCtD
Imatinib—Myalgia—Colchicine—primary biliary cirrhosis	0.000408	0.00177	CcSEcCtD
Imatinib—CA2—liver—primary biliary cirrhosis	0.000404	0.00693	CbGeAlD
Imatinib—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000399	0.00173	CcSEcCtD
Imatinib—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000399	0.00173	CcSEcCtD
Imatinib—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000398	0.00173	CcSEcCtD
Imatinib—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000398	0.00173	CcSEcCtD
Imatinib—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000393	0.00171	CcSEcCtD
Imatinib—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000393	0.00171	CcSEcCtD
Imatinib—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000388	0.00168	CcSEcCtD
Imatinib—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000388	0.00168	CcSEcCtD
Imatinib—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.000387	0.00168	CcSEcCtD
Imatinib—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.000387	0.00168	CcSEcCtD
Imatinib—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000386	0.00167	CcSEcCtD
Imatinib—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000386	0.00167	CcSEcCtD
Imatinib—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000385	0.00167	CcSEcCtD
Imatinib—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000385	0.00167	CcSEcCtD
Imatinib—Shock—Colchicine—primary biliary cirrhosis	0.000385	0.00167	CcSEcCtD
Imatinib—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000383	0.00166	CcSEcCtD
Imatinib—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000383	0.00166	CcSEcCtD
Imatinib—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.00038	0.00165	CcSEcCtD
Imatinib—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.00038	0.00165	CcSEcCtD
Imatinib—Skin disorder—Colchicine—primary biliary cirrhosis	0.00038	0.00165	CcSEcCtD
Imatinib—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000378	0.00164	CcSEcCtD
Imatinib—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000378	0.00164	CcSEcCtD
Imatinib—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000376	0.00163	CcSEcCtD
Imatinib—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000376	0.00163	CcSEcCtD
Imatinib—ABCG2—liver—primary biliary cirrhosis	0.000374	0.00642	CbGeAlD
Imatinib—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.000373	0.00162	CcSEcCtD
Imatinib—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.000373	0.00162	CcSEcCtD
Imatinib—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000372	0.00161	CcSEcCtD
Imatinib—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000372	0.00161	CcSEcCtD
Imatinib—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00159	CcSEcCtD
Imatinib—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00159	CcSEcCtD
Imatinib—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00159	CcSEcCtD
Imatinib—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00159	CcSEcCtD
Imatinib—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00159	CcSEcCtD
Imatinib—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00159	CcSEcCtD
Imatinib—Hypotension—Colchicine—primary biliary cirrhosis	0.000365	0.00159	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000364	0.00158	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000364	0.00158	CcSEcCtD
Imatinib—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000362	0.00157	CcSEcCtD
Imatinib—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000362	0.00157	CcSEcCtD
Imatinib—CYP1A2—liver—primary biliary cirrhosis	0.00036	0.00618	CbGeAlD
Imatinib—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000358	0.00156	CcSEcCtD
Imatinib—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000358	0.00156	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000356	0.00155	CcSEcCtD
Imatinib—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.000354	0.00154	CcSEcCtD
Imatinib—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.000354	0.00154	CcSEcCtD
Imatinib—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000351	0.00152	CcSEcCtD
Imatinib—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000351	0.00152	CcSEcCtD
Imatinib—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000349	0.00151	CcSEcCtD
Imatinib—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000349	0.00151	CcSEcCtD
Imatinib—CYP3A5—liver—primary biliary cirrhosis	0.000347	0.00596	CbGeAlD
Imatinib—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000346	0.0015	CcSEcCtD
Imatinib—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000346	0.0015	CcSEcCtD
Imatinib—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000344	0.00149	CcSEcCtD
Imatinib—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000344	0.00149	CcSEcCtD
Imatinib—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000344	0.00149	CcSEcCtD
Imatinib—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000344	0.00149	CcSEcCtD
Imatinib—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000343	0.00149	CcSEcCtD
Imatinib—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000343	0.00149	CcSEcCtD
Imatinib—CYP2C9—liver—primary biliary cirrhosis	0.000342	0.00587	CbGeAlD
Imatinib—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000341	0.00148	CcSEcCtD
Imatinib—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000341	0.00148	CcSEcCtD
Imatinib—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00034	0.00147	CcSEcCtD
Imatinib—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00034	0.00147	CcSEcCtD
Imatinib—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00034	0.00147	CcSEcCtD
Imatinib—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000338	0.00146	CcSEcCtD
Imatinib—Fatigue—Colchicine—primary biliary cirrhosis	0.000337	0.00146	CcSEcCtD
Imatinib—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000335	0.00145	CcSEcCtD
Imatinib—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000335	0.00145	CcSEcCtD
Imatinib—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000328	0.00142	CcSEcCtD
Imatinib—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000328	0.00142	CcSEcCtD
Imatinib—ABCB1—epithelium—primary biliary cirrhosis	0.000325	0.00559	CbGeAlD
Imatinib—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00032	0.00139	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00032	0.00139	CcSEcCtD
Imatinib—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00032	0.00139	CcSEcCtD
Imatinib—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000318	0.00138	CcSEcCtD
Imatinib—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000318	0.00138	CcSEcCtD
Imatinib—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000315	0.00137	CcSEcCtD
Imatinib—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000315	0.00137	CcSEcCtD
Imatinib—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000313	0.00136	CcSEcCtD
Imatinib—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000313	0.00136	CcSEcCtD
Imatinib—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000312	0.00136	CcSEcCtD
Imatinib—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000312	0.00136	CcSEcCtD
Imatinib—Urticaria—Colchicine—primary biliary cirrhosis	0.000311	0.00135	CcSEcCtD
Imatinib—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000309	0.00134	CcSEcCtD
Imatinib—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000309	0.00134	CcSEcCtD
Imatinib—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000309	0.00134	CcSEcCtD
Imatinib—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000305	0.00133	CcSEcCtD
Imatinib—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000305	0.00133	CcSEcCtD
Imatinib—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000303	0.00132	CcSEcCtD
Imatinib—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000303	0.00132	CcSEcCtD
Imatinib—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000303	0.00131	CcSEcCtD
Imatinib—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000303	0.00131	CcSEcCtD
Imatinib—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.0003	0.0013	CcSEcCtD
Imatinib—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.0003	0.0013	CcSEcCtD
Imatinib—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.0003	0.0013	CcSEcCtD
Imatinib—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.0003	0.0013	CcSEcCtD
Imatinib—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000289	0.00126	CcSEcCtD
Imatinib—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000289	0.00126	CcSEcCtD
Imatinib—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000288	0.00125	CcSEcCtD
Imatinib—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00125	CcSEcCtD
Imatinib—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00125	CcSEcCtD
Imatinib—Asthenia—Colchicine—primary biliary cirrhosis	0.00028	0.00122	CcSEcCtD
Imatinib—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000279	0.00121	CcSEcCtD
Imatinib—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000279	0.00121	CcSEcCtD
Imatinib—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000278	0.00121	CcSEcCtD
Imatinib—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000278	0.00121	CcSEcCtD
Imatinib—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000278	0.00121	CcSEcCtD
Imatinib—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000278	0.00121	CcSEcCtD
Imatinib—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000267	0.00116	CcSEcCtD
Imatinib—CYP3A4—liver—primary biliary cirrhosis	0.000261	0.00447	CbGeAlD
Imatinib—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000259	0.00112	CcSEcCtD
Imatinib—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000259	0.00112	CcSEcCtD
Imatinib—CYP2D6—liver—primary biliary cirrhosis	0.000256	0.0044	CbGeAlD
Imatinib—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000252	0.00109	CcSEcCtD
Imatinib—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000252	0.00109	CcSEcCtD
Imatinib—Vomiting—Colchicine—primary biliary cirrhosis	0.000249	0.00108	CcSEcCtD
Imatinib—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000249	0.00108	CcSEcCtD
Imatinib—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000249	0.00108	CcSEcCtD
Imatinib—Rash—Colchicine—primary biliary cirrhosis	0.000246	0.00107	CcSEcCtD
Imatinib—Dermatitis—Colchicine—primary biliary cirrhosis	0.000246	0.00107	CcSEcCtD
Imatinib—Headache—Colchicine—primary biliary cirrhosis	0.000245	0.00106	CcSEcCtD
Imatinib—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00104	CcSEcCtD
Imatinib—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00104	CcSEcCtD
Imatinib—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000232	0.00101	CcSEcCtD
Imatinib—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000232	0.00101	CcSEcCtD
Imatinib—Nausea—Colchicine—primary biliary cirrhosis	0.000232	0.00101	CcSEcCtD
Imatinib—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000223	0.000969	CcSEcCtD
Imatinib—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000223	0.000969	CcSEcCtD
Imatinib—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000221	0.000961	CcSEcCtD
Imatinib—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000221	0.000961	CcSEcCtD
Imatinib—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000221	0.00096	CcSEcCtD
Imatinib—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000221	0.00096	CcSEcCtD
Imatinib—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00022	0.000955	CcSEcCtD
Imatinib—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00022	0.000955	CcSEcCtD
Imatinib—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000209	0.000905	CcSEcCtD
Imatinib—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000209	0.000905	CcSEcCtD
Imatinib—ABCB1—liver—primary biliary cirrhosis	0.000184	0.00317	CbGeAlD
Imatinib—SLC22A1—Metabolism—NUP210—primary biliary cirrhosis	1.69e-05	0.000134	CbGpPWpGaD
Imatinib—LCK—Immune System—CD79A—primary biliary cirrhosis	1.69e-05	0.000134	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—CD80—primary biliary cirrhosis	1.69e-05	0.000134	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ABCB4—primary biliary cirrhosis	1.69e-05	0.000134	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—DLAT—primary biliary cirrhosis	1.69e-05	0.000134	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ABCG2—primary biliary cirrhosis	1.69e-05	0.000134	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ABCG2—primary biliary cirrhosis	1.69e-05	0.000133	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	1.68e-05	0.000133	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD40LG—primary biliary cirrhosis	1.68e-05	0.000132	CbGpPWpGaD
Imatinib—LCK—Immune System—TAB1—primary biliary cirrhosis	1.66e-05	0.000131	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.66e-05	0.000131	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	1.66e-05	0.000131	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	1.65e-05	0.00013	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	1.65e-05	0.00013	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PDHX—primary biliary cirrhosis	1.64e-05	0.00013	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ABCG2—primary biliary cirrhosis	1.64e-05	0.00013	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.63e-05	0.000129	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—MMP9—primary biliary cirrhosis	1.61e-05	0.000127	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—NFKB1—primary biliary cirrhosis	1.6e-05	0.000127	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—NFKB1—primary biliary cirrhosis	1.59e-05	0.000126	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ABCG2—primary biliary cirrhosis	1.57e-05	0.000124	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—OGDH—primary biliary cirrhosis	1.57e-05	0.000124	CbGpPWpGaD
Imatinib—KIT—Disease—HIF1A—primary biliary cirrhosis	1.57e-05	0.000124	CbGpPWpGaD
Imatinib—CA2—Metabolism—ALB—primary biliary cirrhosis	1.56e-05	0.000124	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.56e-05	0.000123	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	1.56e-05	0.000123	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	1.56e-05	0.000123	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.54e-05	0.000122	CbGpPWpGaD
Imatinib—LCK—Disease—GOT1—primary biliary cirrhosis	1.54e-05	0.000122	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—DLAT—primary biliary cirrhosis	1.54e-05	0.000122	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ABCB4—primary biliary cirrhosis	1.54e-05	0.000122	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.54e-05	0.000122	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.52e-05	0.00012	CbGpPWpGaD
Imatinib—KIT—Immune System—CD80—primary biliary cirrhosis	1.5e-05	0.000119	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.5e-05	0.000119	CbGpPWpGaD
Imatinib—CA1—Metabolism—ALB—primary biliary cirrhosis	1.5e-05	0.000118	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—AGT—primary biliary cirrhosis	1.49e-05	0.000118	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—TYK2—primary biliary cirrhosis	1.49e-05	0.000118	CbGpPWpGaD
Imatinib—PDGFRA—Disease—HIF1A—primary biliary cirrhosis	1.49e-05	0.000117	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	1.47e-05	0.000116	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CTGF—primary biliary cirrhosis	1.46e-05	0.000116	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CTGF—primary biliary cirrhosis	1.45e-05	0.000115	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GOT2—primary biliary cirrhosis	1.45e-05	0.000115	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CTGF—primary biliary cirrhosis	1.45e-05	0.000114	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—NFKB1—primary biliary cirrhosis	1.45e-05	0.000114	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.44e-05	0.000114	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GOT2—primary biliary cirrhosis	1.44e-05	0.000114	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.44e-05	0.000114	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GOT2—primary biliary cirrhosis	1.44e-05	0.000113	CbGpPWpGaD
Imatinib—KIT—Disease—NOS2—primary biliary cirrhosis	1.43e-05	0.000113	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.42e-05	0.000112	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.42e-05	0.000112	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD80—primary biliary cirrhosis	1.42e-05	0.000112	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.42e-05	0.000112	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—NFKB1—primary biliary cirrhosis	1.41e-05	0.000111	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.41e-05	0.000111	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CTGF—primary biliary cirrhosis	1.41e-05	0.000111	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PDHX—primary biliary cirrhosis	1.4e-05	0.000111	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GOT2—primary biliary cirrhosis	1.39e-05	0.00011	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.39e-05	0.00011	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—MMP3—primary biliary cirrhosis	1.39e-05	0.00011	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.39e-05	0.00011	CbGpPWpGaD
Imatinib—KIT—Disease—CD80—primary biliary cirrhosis	1.39e-05	0.000109	CbGpPWpGaD
Imatinib—LCK—Immune System—CD40LG—primary biliary cirrhosis	1.38e-05	0.000109	CbGpPWpGaD
Imatinib—PDGFRA—Disease—NOS2—primary biliary cirrhosis	1.35e-05	0.000107	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CTGF—primary biliary cirrhosis	1.35e-05	0.000107	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GOT2—primary biliary cirrhosis	1.34e-05	0.000106	CbGpPWpGaD
Imatinib—PDGFRB—Disease—HIF1A—primary biliary cirrhosis	1.34e-05	0.000106	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CD80—primary biliary cirrhosis	1.32e-05	0.000105	CbGpPWpGaD
Imatinib—CA9—Metabolism—ALB—primary biliary cirrhosis	1.32e-05	0.000104	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ABCB4—primary biliary cirrhosis	1.32e-05	0.000104	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—DLAT—primary biliary cirrhosis	1.32e-05	0.000104	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—NUP210—primary biliary cirrhosis	1.32e-05	0.000104	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—MMP3—primary biliary cirrhosis	1.31e-05	0.000104	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.31e-05	0.000104	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CD80—primary biliary cirrhosis	1.31e-05	0.000104	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CCL5—primary biliary cirrhosis	1.31e-05	0.000103	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.3e-05	0.000102	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD80—primary biliary cirrhosis	1.28e-05	0.000101	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.27e-05	0.0001	CbGpPWpGaD
Imatinib—KIT—Immune System—TYK2—primary biliary cirrhosis	1.27e-05	0.0001	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.26e-05	9.99e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GGT1—primary biliary cirrhosis	1.25e-05	9.9e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GOT1—primary biliary cirrhosis	1.25e-05	9.9e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD80—primary biliary cirrhosis	1.25e-05	9.85e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GGT1—primary biliary cirrhosis	1.24e-05	9.81e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GOT1—primary biliary cirrhosis	1.24e-05	9.81e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GGT1—primary biliary cirrhosis	1.24e-05	9.8e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GOT1—primary biliary cirrhosis	1.24e-05	9.8e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CCL5—primary biliary cirrhosis	1.24e-05	9.79e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ABCG2—primary biliary cirrhosis	1.22e-05	9.66e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—NOS2—primary biliary cirrhosis	1.22e-05	9.62e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	1.21e-05	9.59e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.21e-05	9.59e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—NOS2—primary biliary cirrhosis	1.21e-05	9.53e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GGT1—primary biliary cirrhosis	1.2e-05	9.51e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GOT1—primary biliary cirrhosis	1.2e-05	9.51e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.2e-05	9.51e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.2e-05	9.49e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—TYK2—primary biliary cirrhosis	1.2e-05	9.47e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MMP3—primary biliary cirrhosis	1.18e-05	9.35e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CD80—primary biliary cirrhosis	1.18e-05	9.33e-05	CbGpPWpGaD
Imatinib—KIT—Disease—TYK2—primary biliary cirrhosis	1.17e-05	9.24e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—NFKB1—primary biliary cirrhosis	1.16e-05	9.16e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GOT1—primary biliary cirrhosis	1.16e-05	9.13e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GGT1—primary biliary cirrhosis	1.16e-05	9.13e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—NUP210—primary biliary cirrhosis	1.13e-05	8.95e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TYK2—primary biliary cirrhosis	1.12e-05	8.83e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CCL5—primary biliary cirrhosis	1.12e-05	8.82e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PPARGC1A—primary biliary cirrhosis	1.11e-05	8.81e-05	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.11e-05	8.8e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—TYK2—primary biliary cirrhosis	1.11e-05	8.75e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PPARGC1A—primary biliary cirrhosis	1.11e-05	8.73e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PPARGC1A—primary biliary cirrhosis	1.1e-05	8.72e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.1e-05	8.68e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—AGT—primary biliary cirrhosis	1.1e-05	8.65e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	1.08e-05	8.55e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.08e-05	8.55e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.08e-05	8.54e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—TYK2—primary biliary cirrhosis	1.08e-05	8.53e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.08e-05	8.53e-05	CbGpPWpGaD
Imatinib—LCK—Disease—HIF1A—primary biliary cirrhosis	1.07e-05	8.49e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PPARGC1A—primary biliary cirrhosis	1.07e-05	8.46e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—ABCG2—primary biliary cirrhosis	1.05e-05	8.32e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—TYK2—primary biliary cirrhosis	1.05e-05	8.32e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CTGF—primary biliary cirrhosis	1.05e-05	8.29e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.04e-05	8.22e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.04e-05	8.22e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GOT2—primary biliary cirrhosis	1.04e-05	8.22e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—AGT—primary biliary cirrhosis	1.04e-05	8.19e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PPARGC1A—primary biliary cirrhosis	1.03e-05	8.12e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—CD80—primary biliary cirrhosis	1.03e-05	8.11e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	1.02e-05	8.04e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	1.02e-05	8.04e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—NUP210—primary biliary cirrhosis	1.02e-05	8.03e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—TYK2—primary biliary cirrhosis	9.98e-06	7.88e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	9.93e-06	7.84e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—NFKB1—primary biliary cirrhosis	9.87e-06	7.8e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	9.85e-06	7.78e-05	CbGpPWpGaD
Imatinib—LCK—Disease—NOS2—primary biliary cirrhosis	9.77e-06	7.72e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CD80—primary biliary cirrhosis	9.7e-06	7.66e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MMP3—primary biliary cirrhosis	9.49e-06	7.5e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CD80—primary biliary cirrhosis	9.48e-06	7.49e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ABCG2—primary biliary cirrhosis	9.46e-06	7.47e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HIF1A—primary biliary cirrhosis	9.38e-06	7.41e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	9.35e-06	7.39e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—NFKB1—primary biliary cirrhosis	9.34e-06	7.38e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—AGT—primary biliary cirrhosis	9.34e-06	7.38e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—NUP210—primary biliary cirrhosis	9.27e-06	7.33e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	9.23e-06	7.29e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CD80—primary biliary cirrhosis	9.18e-06	7.26e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CTGF—primary biliary cirrhosis	9.04e-06	7.14e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GGT1—primary biliary cirrhosis	8.98e-06	7.09e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GOT1—primary biliary cirrhosis	8.98e-06	7.09e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCL5—primary biliary cirrhosis	8.96e-06	7.08e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GOT2—primary biliary cirrhosis	8.96e-06	7.07e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—MMP9—primary biliary cirrhosis	8.8e-06	6.95e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NFKB1—primary biliary cirrhosis	8.71e-06	6.88e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	8.7e-06	6.87e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—AGT—primary biliary cirrhosis	8.68e-06	6.86e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	8.68e-06	6.86e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—TYK2—primary biliary cirrhosis	8.67e-06	6.85e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ABCG2—primary biliary cirrhosis	8.62e-06	6.81e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—AGT—primary biliary cirrhosis	8.61e-06	6.8e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—AGT—primary biliary cirrhosis	8.59e-06	6.79e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—NFKB1—primary biliary cirrhosis	8.42e-06	6.65e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	8.42e-06	6.65e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—AGT—primary biliary cirrhosis	8.34e-06	6.59e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	8.29e-06	6.55e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CD80—primary biliary cirrhosis	8.27e-06	6.54e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—NFKB1—primary biliary cirrhosis	8.2e-06	6.48e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TYK2—primary biliary cirrhosis	8.19e-06	6.47e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CTGF—primary biliary cirrhosis	8.11e-06	6.41e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GOT2—primary biliary cirrhosis	8.04e-06	6.35e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—AGT—primary biliary cirrhosis	8.01e-06	6.33e-05	CbGpPWpGaD
Imatinib—LCK—Disease—TYK2—primary biliary cirrhosis	8.01e-06	6.32e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PPARGC1A—primary biliary cirrhosis	7.99e-06	6.31e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NUP210—primary biliary cirrhosis	7.92e-06	6.26e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	7.92e-06	6.25e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	7.85e-06	6.2e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TYK2—primary biliary cirrhosis	7.75e-06	6.12e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GOT1—primary biliary cirrhosis	7.73e-06	6.11e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GGT1—primary biliary cirrhosis	7.73e-06	6.11e-05	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	7.69e-06	6.08e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	7.56e-06	5.97e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HIF1A—primary biliary cirrhosis	7.52e-06	5.94e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—AGT—primary biliary cirrhosis	7.5e-06	5.92e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	7.46e-06	5.89e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CTGF—primary biliary cirrhosis	7.4e-06	5.84e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	7.39e-06	5.84e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ABCG2—primary biliary cirrhosis	7.37e-06	5.82e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GOT2—primary biliary cirrhosis	7.33e-06	5.79e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TYK2—primary biliary cirrhosis	6.99e-06	5.52e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GGT1—primary biliary cirrhosis	6.94e-06	5.48e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GOT1—primary biliary cirrhosis	6.94e-06	5.48e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PPARGC1A—primary biliary cirrhosis	6.88e-06	5.44e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	6.77e-06	5.35e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	6.77e-06	5.35e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—NFKB1—primary biliary cirrhosis	6.76e-06	5.34e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ALB—primary biliary cirrhosis	6.66e-06	5.26e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CD80—primary biliary cirrhosis	6.64e-06	5.25e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ALB—primary biliary cirrhosis	6.61e-06	5.22e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ALB—primary biliary cirrhosis	6.6e-06	5.21e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	6.46e-06	5.1e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—MMP9—primary biliary cirrhosis	6.45e-06	5.1e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ALB—primary biliary cirrhosis	6.4e-06	5.06e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	6.38e-06	5.04e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	6.38e-06	5.04e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NFKB1—primary biliary cirrhosis	6.38e-06	5.04e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GOT1—primary biliary cirrhosis	6.33e-06	5e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GGT1—primary biliary cirrhosis	6.33e-06	5e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CTGF—primary biliary cirrhosis	6.32e-06	4.99e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GOT2—primary biliary cirrhosis	6.26e-06	4.95e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—AGT—primary biliary cirrhosis	6.22e-06	4.92e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PPARGC1A—primary biliary cirrhosis	6.18e-06	4.88e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ALB—primary biliary cirrhosis	6.15e-06	4.86e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	6.12e-06	4.83e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—MMP9—primary biliary cirrhosis	6.11e-06	4.82e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NFKB1—primary biliary cirrhosis	6.04e-06	4.77e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	6.03e-06	4.76e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	5.69e-06	4.49e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	5.68e-06	4.49e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PPARGC1A—primary biliary cirrhosis	5.63e-06	4.45e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TYK2—primary biliary cirrhosis	5.61e-06	4.43e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MMP9—primary biliary cirrhosis	5.5e-06	4.35e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NFKB1—primary biliary cirrhosis	5.44e-06	4.3e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GGT1—primary biliary cirrhosis	5.41e-06	4.27e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GOT1—primary biliary cirrhosis	5.41e-06	4.27e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—AGT—primary biliary cirrhosis	5.36e-06	4.23e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	4.88e-06	3.85e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	4.83e-06	3.82e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	4.81e-06	3.8e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—AGT—primary biliary cirrhosis	4.81e-06	3.8e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ALB—primary biliary cirrhosis	4.77e-06	3.77e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—AGT—primary biliary cirrhosis	4.7e-06	3.71e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	4.42e-06	3.5e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MMP9—primary biliary cirrhosis	4.41e-06	3.49e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—AGT—primary biliary cirrhosis	4.39e-06	3.46e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.37e-06	3.45e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	4.17e-06	3.3e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	4.17e-06	3.3e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—AGT—primary biliary cirrhosis	3.75e-06	2.96e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	3.71e-06	2.93e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ALB—primary biliary cirrhosis	3.69e-06	2.92e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ALB—primary biliary cirrhosis	3.6e-06	2.85e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	3.4e-06	2.68e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ALB—primary biliary cirrhosis	3.37e-06	2.66e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	2.89e-06	2.29e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ALB—primary biliary cirrhosis	2.88e-06	2.27e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	2.22e-06	1.75e-05	CbGpPWpGaD
